Ana Alfirevic
- Pharmacology top 0.5%
- Immunology top 2%
- Pharmacology top 0.5%
- Molecular Biology
- Oncology top 5%
- Co-authors
- Munir PirmohamedAndrea JorgensenAndrew R. JonesFaviel F. González-GalarzaEduardo José Melo dos SantosDerek MiddletonLouise Y.C. TakeshitaF. Javier Vilar
- Topics
- Drug-Induced Adverse Reactions (32 papers)Pharmacogenetics and Drug Metabolism (15 papers)Pharmaceutical studies and practices (9 papers)
- Cited by
- PharmacologyToxicology
- Journals
- Nucleic Acids ResearchSHILAP Revista de lepidopterologíaThe Journal of Immunology
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Ana Alfirevic
95 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Pharmacology 1.2k
- Immunology 1.1k
- Pharmacology 712
- Molecular Biology 630
- Oncology 492
Countries citing papers authored by Ana Alfirevic
This map shows the geographic impact of Ana Alfirevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Alfirevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Alfirevic more than expected).
Fields of papers citing papers by Ana Alfirevic
This network shows the impact of papers produced by Ana Alfirevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Alfirevic. The network helps show where Ana Alfirevic may publish in the future.
Co-authorship network of co-authors of Ana Alfirevic
This figure shows the co-authorship network connecting the top 25 collaborators of Ana Alfirevic. A scholar is included among the top collaborators of Ana Alfirevic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Alfirevic. Ana Alfirevic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 30 | |
| 6 | 13 | |
| 7 | 26 | |
| 8 | 17 | |
| 9 | 1 | |
| 10 | 11 | |
| 11 | 4 | |
| 12 | 6 | |
| 13 | 3 | |
| 14 | 13 | |
| 15 | 58 | |
| 16 | 26 | |
| 17 | 0 | |
| 18 | 27 | |
| 19 | 48 | |
| 20 | 74 |
About Ana Alfirevic
Ana Alfirevic is a scholar working on Pharmacology, Pharmacology and Biological Psychiatry, having authored 98 papers that have together received 4.0k indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (32 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Pharmaceutical studies and practices (9 papers). The work is most often cited by research in Pharmacology (712 citations), Pharmacology (1.2k citations) and Toxicology (187 citations). Ana Alfirevic has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Munir Pirmohamed, Andrea Jorgensen, Andrew R. Jones, Faviel F. González-Galarza, Eduardo José Melo dos Santos, Derek Middleton, Louise Y.C. Takeshita, F. Javier Vilar, Dyfrig Hughes and María Helena Thomaz Maia. Their work appears in journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.